Literature DB >> 30481807

Relationship Between Eyelid Pressure and Ocular Surface Disorders in Patients With Healthy and Dry Eyes.

Masahiko Yamaguchi1,2, Atsushi Shiraishi2.   

Abstract

Purpose: To determine whether an eyelid pressure measurement device, called a blepharo-tensiometer, can detect changes in the eyelid pressure in different types of ocular surface disorders.
Methods: First, the repeatability of the blepharo-tensiometer was determined by measuring the eyelid pressures on 3 separate days from healthy volunteers and calculating the intraclass correlation coefficients (ICCs). Second, to determine the ability of the blepharo-tensiometer to detect changes in the eyelid pressures in different types of ocular surface disorders, we compared the eyelid pressure of healthy eyes with dry eyes. Third, the correlations between the eyelid pressure and the location and magnitude of fluorescein staining of the ocular surface were analyzed. Fourth, the eyelid pressure in eyes with lid-wiper epitheliopathy (LWE) was measured.
Results: The ICCs ranged from 0.675 to 0.911 for the upper eyelid and 0.663 to 0.925 for the lower eyelid. The pressures of the upper and lower eyelids were significantly higher in dry eyes than in healthy eyes. The inferior ocular surface staining scores were strongly correlated with the lower eyelid pressure by multivariate analysis. The lower eyelid pressure was significantly correlated with the grade of the lower LWE. Conclusions: The blepahro-tensiometer can obtain repeatable measurements of the eyelid pressure and can be used to evaluate the pressure of the eyelids on the ocular surface in healthy and diseased eyes. The significant correlations between the eyelid pressure and the ocular surface staining suggests that the pressure on the ocular surface probably contributes to ocular surface disorders.

Entities:  

Mesh:

Year:  2018        PMID: 30481807     DOI: 10.1167/iovs.17-23586

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

Review 1.  Impact of Attrition, Intercellular Shear in Dry Eye Disease: When Cells are Challenged and Neurons are Triggered.

Authors:  Gysbert-Botho van Setten
Journal:  Int J Mol Sci       Date:  2020-06-18       Impact factor: 5.923

2.  Change in the geometry of positive- and negative-powered soft contact lenses during wear.

Authors:  Bartlomiej J Kaluzny; Joanna Stachura; Patryk Mlyniuk; Alfonso Jimenez-Villar; Magdalena Wietlicka-Piszcz; Ireneusz Grulkowski
Journal:  PLoS One       Date:  2020-11-09       Impact factor: 3.240

3.  Tuning corneal epithelial cell adhesive strength with varying crosslinker content in silicone hydrogel materials.

Authors:  Chunzi Liu; Charles W Scales; Gerald G Fuller
Journal:  Transl Vis Sci Technol       Date:  2020-05-11       Impact factor: 3.283

Review 4.  Why Chain Length of Hyaluronan in Eye Drops Matters.

Authors:  Wolfgang G K Müller-Lierheim
Journal:  Diagnostics (Basel)       Date:  2020-07-23

5.  Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A.

Authors:  Supharat Jariyakosol; Lita Uthaithammarat; Nattakarn Chatwichaikul; Ngamjit Kasetsuwan; Yuda Chongpison
Journal:  Clin Ophthalmol       Date:  2021-04-28

6.  Measurement of the Lid Margin Thickness in Meibomian Gland Dysfunction with Vernier Micrometer.

Authors:  Hua-Ying Zhu; Xin-Quan Liu; Yuan-Zhi Yuan; Da-Hu Wang
Journal:  Ophthalmol Ther       Date:  2021-11-11

7.  Assessment of Eyelid Pressure Using a Novel Pressure Measurement Device in Patients With Moderate-to-Severe Dry Eye Disease.

Authors:  Jingyi Wang; Jiayu Bao; Wenxiu Song; Siyuan Li; Yiran Hao; Lei Tian; Ying Jie
Journal:  Front Med (Lausanne)       Date:  2022-02-07

Review 8.  Unraveling the mechanobiology of cornea: From bench side to the clinic.

Authors:  Shu Yang; Jing Zhang; Youhua Tan; Yan Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-10-03

9.  Periorbital injections of botulinum toxin a: a novel therapeutic option for convergence spasm in neuropsychiatric disorders.

Authors:  Kristina Hess; Moritz Schmitt; Bettina Wabbels
Journal:  J Neurol       Date:  2021-05-28       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.